What’s next for biotech in Europe — a Bio€quity preview podcast

Special guests join BioCentury to discuss how industry can navigate the new complexity. Plus: the Belgian biotech ecosystem

This year’s Bio€quity Europe conference — the 25th edition of the event — will focus on what’s next for Europe amid biotech’s current complex moment, Editor in Chief Simone Fishburn said on a special edition of the BioCentury This Week podcast previewing the meeting, which kicks off May 12 in Bruges, Belgium. 

McKinsey & Co.’s Alexandra Zemp and Henk Joos, an investment specialist at Medvia, which fosters health innovation in Flanders and is part of the conference’s regional host committee, joined Fishburn, BioCentury co-founder, President and CEO David Flores, Executive Editor Jeff Cranmer, and Head of BD Joshua Berlin to discuss the state of Belgium’s biopharma ecosystem and preview some of the conference’s networking events, fireside chats and panel discussions.

Claire Macht, portfolio director, Europe, of BioCentury’s conference partner EBD Group, also joined the podcast to detail what to expect in terms of one-on-one partnering meetings at the event.

Bio€quity Europe 2025 is sold out, but space on the waitlist remains, and digital passes are available. See the conference website for more information.